Carotid Stenosis: Clinical Trials

27 trials for Carotid Stenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 7 terminated, 4 unknown, 4 withdrawn. 27 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 227Completed 8, Terminated 7, Unknown 4, Withdrawn 4, Recruiting 2, Active not recruiting 1, Suspended 1
Phase 12Withdrawn 2
Phase 31Terminated 1

Follow Carotid Stenosis: new trials by email Literature Review of Carotid Stenosis trials Research Report on Carotid Stenosis

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAROTID STABILISE Pilot: Alirocumab for Symptomatic Carotid Stenosis
Alirocumab, Matching placebo - Carotid Artery Stenosis
Phase 2CompletedMiddle East North Africa Stroke and Interventional Neurotherapies Organization402026-01-062026-11-16
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
[18F]AlF-OC - Stroke (CVA) or TIA, Carotid Artery Plaque
Phase 2RecruitingUniversitaire Ziekenhuizen KU Leuven242025-03-182025-08-11
Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2
[18F]DPA-714 PET/MRI - CAROTID STENOSIS
Phase 2RecruitingHospices Civils de Lyon202024-02-132025-02-06
Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis
68GaNOTA-Anti-MMR-VHH2 - Solid Malignancy Located in the Head and Neck, Cancer
Phase 2TerminatedUniversitair Ziekenhuis Brussel292021-01-262026-06-01
Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation
18F-FPPRGD2, Positron emission tomography, Computed tomography - Aortic Aneurysm, Abdominal, Carotid Atherosclerosis
Phase 2WithdrawnStanford University2019-10-012021-05-21
Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy
Sodium fluoride F-18 PET imaging - Carotid Artery Stenosis
Phase 2UnknownUniversity Hospital, Caen202018-09-032020-01-13
Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
Terazosin, Carotid artery stenting - Carotid Artery Stenosis
Phase 2UnknownCapital Medical University1602018-03-022018-12-11
New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques
Contrast-enhanced ultrasound, Shear Wave Elastography, Ultrasound Examination - Carotid Artery Plaque
Phase 2CompletedMayo Clinic542017-11-152022-11-25
Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine
Herbal Medicine C-117, The Placebo of Herbal Medicine C-117 - Carotid Artery Plaque
Phase 2UnknownGuangzhou University of Traditional Chinese Medicine1202017-03-012017-03-07
The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition
Imaging with flutemetamol F 18 PET/CT - Cognitive Impairment, Carotid Artery Plaque
Phase 2Active not recruitingScott Mcnally452017-02-172026-05-13
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
Atorvastatin, Placebo - Nasopharyngeal Carcinoma, Radiation Therapy Complication
Phase 2SuspendedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3242017-01-012017-12-04
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
Ticagrelor, Clopidogrel, Aspirin - Carotid Artery Stenosis
Phase 2CompletedUniversity Hospital, Basel, Switzerland2102016-12-012022-06-28
99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis
99mTc-rhAnnexin V-128 - Carotid Artery Plaque
Phase 2TerminatedAdvanced Accelerator Applications392016-06-232020-10-09
The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis
EP 1645/Solution For Injection, 99mTC - Carotid Stenosis
Phase 2UnknownTechnische Universität Dresden212015-01-012012-02-03
TRACER RGD-K5 Carotid Plaque Imaging Study
[F-18] RDG-K5 - Carotid Artery Disease, Carotid Stenosis
Phase 2TerminatedThe Cleveland Clinic32013-11-012017-09-12
Revacept in Symptomatic Carotid Stenosis
Revacept, Placebo - Carotid Stenosis, Atherosclerosis
Phase 2CompletedAdvanceCor GmbH1582013-03-082021-01-28
Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting
Remote ischemic preconditioning, Sham remote ischemic preconditioning, Carotid Artery Stenting - Carotid Artery Stenosis
Phase 2CompletedJi Xunming1892012-07-012015-11-11
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
[F-18]RDG-K5 - Carotid Stenosis
Phase 2TerminatedSiemens Molecular Imaging52012-05-012013-09-27
Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy
ARC1779 Injection, Placebo (normal saline) - Intracranial Embolism, Cerebral Thromboembolism
Phase 2TerminatedArchemix Corp.1002009-02-012010-02-10
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
Fasudil Hydrochloride, Placebo Oral Tablet - Carotid Stenosis
Phase 2TerminatedBrigham and Women's Hospital22008-03-132017-03-29

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Cerebrovascular Disorders (4)  ·  Inflammation (4)  ·  Stroke (4)  ·  Atherosclerosis (3)  ·  Carotid Artery Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Intracranial Embolism (2)  ·  Vascular Diseases (2)  ·  Amaurosis Fugax (1)  ·  Aortic Aneurysm, Abdominal (1)  ·  Cognitive Dysfunction (1)  ·  Constriction, Pathologic (1)  ·  Fatty Liver (1)

Broader conditions

Arterial Occlusive Diseases (27)  ·  Brain Diseases (27)  ·  Central Nervous System Diseases (27)  ·  Nervous System Diseases (27)  ·  Cardiovascular Diseases (25)  ·  Vascular Diseases (25)  ·  Carotid Artery Diseases (24)  ·  Cerebrovascular Disorders (23)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Arteriosclerosis (4)  ·  Pathologic Processes (4)  ·  Embolism and Thrombosis (3)  ·  Eye Diseases (2)  ·  Intracranial Embolism and Thrombosis (2)  ·  Neoplasms by Histologic Type (2)

Interventions

Aspirin (3)  ·  18F-RGD-K5 (1)  ·  ARC 1779 (1)  ·  Abciximab (1)  ·  Atorvastatin (1)  ·  Clopidogrel (1)  ·  Control Groups (1)  ·  Dipyridamole (1)  ·  Embolic Protection Devices (1)  ·  FPP(RGD)2 (1)  ·  Injections (1)  ·  Lovastatin (1)  ·  Magnetic Resonance Imaging (1)  ·  Minocycline (1)  ·  Positron-Emission Tomography (1)

Sponsors

Brigham and Women's Hospital (2)  ·  AdvanceCor GmbH (1)  ·  Advanced Accelerator Applications (1)  ·  Archemix Corp. (1)  ·  Capital Medical University (1)  ·  Emory University (1)  ·  Guangzhou University of Traditional Chinese Medicine (1)  ·  Hospices Civils de Lyon (1)  ·  Ji Xunming (1)  ·  Kensey Nash Corporation (1)  ·  Mayo Clinic (1)  ·  Middle East North Africa Stroke and Interventional Neurotherapies Organization (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Scott Mcnally (1)  ·  Siemens Molecular Imaging (1)

Countries

United States (10)  ·  Belgium (3)  ·  China (3)  ·  Germany (3)  ·  United Kingdom (3)  ·  France (2)  ·  Canada (1)  ·  Egypt (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Balaji Tamarappoo, MD, PhD (2)  ·  Anju Nohria, MD (1)  ·  Christoph Schindler Schindler, MD (1)  ·  Curt Furberg (1)  ·  Edward Aten, MD (1)  ·  Gary S Roubin, MD (1)  ·  Holger Poppert, Prof. Dr. (1)  ·  Hugh Markus, MD (1)  ·  Ian M Loftus, MD (1)  ·  Jianwen Guo, MD (1)  ·  Joseph S McNally, MD, PhD (1)  ·  Leo H Bonati, MD (1)  ·  Mark Espeland (1)  ·  Matthew W Urban (1)

Results publications

PMID 21700934, PMID 24373555, PMID 24699052, PMID 28174194, PMID 30957581, PMID 31391862, PMID 35695006, PMID 36645250, PMID 37565307

NIH funding

2008 (1), 2023 (1), R01HL038194 (1), R37HL041619 (1)